The Boston Scientific Vercise Genus is a directional DBS system featuring a rechargeable neurostimulator with multi-source current control — each electrode contact can be driven by an independent current source, enabling precise spatial steering of the therapeutic field. The system integrates with Boston Scientific's Neural Navigator programming software, supports Qi wireless charging, and pairs with the GUIDE XT imaging visualization tool for precise lead placement planning. The Genus platform supports both constant voltage and constant current stimulation modes.
The device has received Pre-Market Approval (PMA) from the FDA, the most stringent device marketing pathway. PMA approval means FDA has found there is reasonable assurance the device is safe and effective.
FDA Device Regulatory Guidance ↗